Table 2.
A list of miRNAs demonstrated to target FOXO mRNA simultaneously
| miRNA | Target mRNA | Target cell/tissue or biological process (organisma) | Reference |
|---|---|---|---|
| miR‐9, miR‐27, miR‐96, miR‐153, miR‐182, miR‐183 and miR‐186 | FOXO1 | Endometrial cancer (Hs) | Myatt et al. (2010) |
| miR‐27a, miR‐96 and miR‐182 | FOXO1 | Breast cancer cells (Hs) | Guttilla and White (2009) |
| miR‐27a and miR‐24 | FOXO1 | Differentiation of embryonic stem cells (Mm) | Ma et al. (2015) |
| miR‐96, miR‐182 and miR‐183 | FOXO1 | Classical Hodgkin lymphoma (Hs) | Xie et al. (2012) |
| miR‐96, miR‐182 and miR‐183 | FOXO1 | Glioma (Hs) | Tang et al. (2013) |
| miR‐96, miR‐182 and miR‐183 | FOXO1 | Granulosa cells (Bt) | Gebremedhn et al. (2015) |
| miR‐96, miR‐182 and miR‐183 | FOXO1 | Hepatocellular carcinoma (Hs) | Leung et al. (2015) |
| miR‐96 and miR‐182 | FOXO3 | Ovarian cancer cells (Hs) | Xu et al. (2013b) |
| miR‐132 and miR‐212 | FOXO3 | Cardiac hypertrophy and cardiomyocyte autophagy (Mm and Rn) | Ucar et al. (2012) |
| miR‐132 and miR‐212 | FOXO3 | Alzheimer's disease (Hs, Mm and Rn) | Wong et al. (2013) |
| miR‐132 and miR‐212 | FOXO3 | Haematopoietic stem cell maintenance (Mm) | Mehta et al. (2015) |
| miR‐182 and miR‐223 | FOXO3 | Skeletal muscle – hormone replacement therapy (Hs and Mm) | Olivieri et al. (2014) |
a
Hs, human; Mm, mouse; Rn, rat; Bt, bovine.